For citations:
Hamieh L., Beck R.L., Le V.H., Hsieh J.J. The efficacy of lenvatinib plus everolimus in patients with metastatic renal cell carcinoma exhibiting primary resistance to front-line targeted therapy or immunotherapy. Cancer Urology. 2020;16(3):53-61. (In Russ.) https://doi.org/10.17650/1726-9776-2020-16-3-53-61
Email this article 